Aparajita Lath Global Health Health Law Policy Intellectual Property Market Design Pharmaceuticals Public Health Reimbursement Resource Allocation Student Fellows Vaccines Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Aparajita Lath Global Health Intellectual Property International Pharmaceuticals Scientific Evidence Student Fellows Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier Read more: Proposed Amendments Would Make Foreign Investment in India’s Biological Resources Easier
Biotechnology Generic Drugs Global Health Health Law and Policy in an Era of Mass Suffering Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Vaccines Reclaiming Global Public Health Read more: Reclaiming Global Public Health
Biotechnology Featured Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Vaccines COVID ‘Compromise’ on International IP Underscores Need for New Approach Read more: COVID ‘Compromise’ on International IP Underscores Need for New Approach
Biotechnology Generic Drugs Global Health Health Law Policy Intellectual Property International International Pandemic Lawmaking: Conceptual and Practical Issues Market Design Pharmaceuticals Public Health Resource Allocation Vaccines Decolonizing the Pandemic Treaty Through Vaccine Equity Read more: Decolonizing the Pandemic Treaty Through Vaccine Equity
Biotechnology Featured Generic Drugs Global Health Health Law Policy Intellectual Property International International Pandemic Lawmaking: Conceptual and Practical Issues Market Design Pharmaceuticals Public Health Resource Allocation Vaccines The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good Read more: The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good
Biotechnology COVID-19, Social Movements, and Health Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Vaccines Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic Read more: Access-to-Medicines Activists Demand Health Justice During COVID-19 Pandemic
Biotechnology Generic Drugs Global Health Health Law Policy Intellectual Property International Market Design Pharmaceuticals Public Health Resource Allocation Timo Minssen Vaccines The Prospects for an IP Waiver Under the TRIPS Agreement Read more: The Prospects for an IP Waiver Under the TRIPS Agreement
Addiction Announcements Chloe Reichel FDA Featured Health Law Policy Informed Consent Insurance Intellectual Property Mason Marks Mental Health Neuroscience Off-Label Use Opioid Crisis Petrie-Flom Center Pharmaceuticals Public Health Race Research Funding Scientific Evidence Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative Read more: Q&A with Mason Marks on New Psychedelics Law and Regulation Initiative
Biotechnology Featured Generic Drugs Global Health Health Law Policy Intellectual Property International Jorge Contreras Market Design Pharmaceuticals Public Health Resource Allocation Vaccines US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean? Read more: US Support for a WTO Waiver of COVID-19 Intellectual Property – What Does it Mean?